| CAS NO: | 841205-47-8 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| 500mg | 电议 |
| Cas No. | 841205-47-8 |
| Canonical SMILES | FC(F)(C1=CC(NC([C@](C)(COC2=CC=C(C=C2)C#N)O)=O)=CC=C1C#N)F |
| 分子式 | C19H14F3N3O3 |
| 分子量 | 389.33 |
| 溶解度 | DMSO: ≥ 100 mg/mL (256.85 mM); Water:< 0.1 mg/mL (insoluble) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Ostarine(MK-2866; GTX-024) is a modulator of human androgen receptor.IC50 value:Target: androgen receptorOstarine (MK-2866) is an androgen receptor modulator (SARM) with an ED50 of 0.44 mg/day. Ostarine (MK-2866) has anabolic activity. Lack of PSA increases in men and hair growth in women further corroborated selective anabolic effects of Ostarine (MK-2866). Ostarine (MK-2866) also resulted in a dose-dependent decrease in LDL and HDL cholesterol levels, with the average LDL/HDL ratio for all doses remaining in the low cardiovascular risk catergory. [1]. Thevis M, et al. Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet.Drug Test Anal. 2011 May;3(5):331-6. doi: 10.1002/dta.283. [2]. Zilbermint MF, et al. Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia. Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia. |
m.cnreagent.com